Anti-angiogenic actions of pyrrolidine dithiocarbamate, a nuclear factor kappa B inhibitor

Renal cell carcinomas (RCC) are a heterogeneous group of cancers that often include angiogenesis as a key clinical and pathological hallmark. As the transcription factor nuclear factor kappa B (NF-κB) has been identified as a key promoter of angiogenesis, NF-κB inhibitors could serve as potential an...

Ausführliche Beschreibung